Your browser doesn't support javascript.
loading
Chemotherapy Resistance in B-ALL with Cryptic NUP214-ABL1 Is Amenable to Kinase Inhibition and Immunotherapy.
Nardi, Valentina; McAfee, Steven L; Dal Cin, Paola; Tsai, Harrison K; Amrein, Philip C; Hobbs, Gabriela S; Brunner, Andrew M; Narayan, Rupa; Foster, Julia; Fathi, Amir T; Hock, Hanno.
  • Nardi V; Harvard Medical School, Boston, MA, USA.
  • McAfee SL; Department of Pathology, Massachusetts General Hospital, Boston, MA, USA.
  • Dal Cin P; Harvard Medical School, Boston, MA, USA.
  • Tsai HK; Cancer Center, Massachusetts General Hospital, Boston, MA, USA.
  • Amrein PC; Harvard Medical School, Boston, MA, USA.
  • Hobbs GS; Department of Pathology, Brigham and Women's Hospital, Boston, MA, USA.
  • Brunner AM; Harvard Medical School, Boston, MA, USA.
  • Narayan R; Department of Pathology, Boston Children's Hospital, Boston, MA, USA.
  • Foster J; Harvard Medical School, Boston, MA, USA.
  • Fathi AT; Cancer Center, Massachusetts General Hospital, Boston, MA, USA.
  • Hock H; Harvard Medical School, Boston, MA, USA.
Oncologist ; 27(2): 82-86, 2022 03 04.
Article en En | MEDLINE | ID: mdl-35641210
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Leucemia-Linfoma Linfoblástico de Células Precursoras Tipo de estudio: Prognostic_studies Límite: Humans / Male Idioma: En Año: 2022 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Leucemia-Linfoma Linfoblástico de Células Precursoras Tipo de estudio: Prognostic_studies Límite: Humans / Male Idioma: En Año: 2022 Tipo del documento: Article